(3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone | CAS:68711-40-0

We serve (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone CAS:68711-40-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone

Chemical Name:(3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone
CAS.NO:68711-40-0
Synonyms:(3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone
3S,4S-3-HEXYL-4-((S))-2-HYDROXYTRIDECYL)-2-OXETANONE
(3S,4S)-3-hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one
(3S,4S)-3-Hexyl-4-[(S)-2-hydroxytridecyl]-2-oxetanone
(3S,4S)-3-Hexyl-4-((S)-2-hydroxytridecyl)oxetan-2-one
 
Physical and Chemical Properties:
Molecular Formula C22H42O3
Molecular Weight 354.56700
 
Specification:
Appearance:White to off-white powder
Assay:≥95.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Orlistat(CAS:96829-58-2).



Contact us for information like (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3S,4S)-3-Hexyl-4-((S)-2-hydroxytridecyl)oxetan-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3S,4S)-3-Hexyl-4-[(S)-2-hydroxytridecyl]-2-oxetanone Use and application,(3S,4S)-3-hexyl-4-((R)-2-hydroxytridecyl)-oxetan-2-one technical grade,usp/ep/jp grade.


Related News: There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.cyclopropanecarboxylic acid manufacturer There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.1-Chlorododecane supplier The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.4-nitrobenzene-1,3-diamine,sulfuric acid vendor The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.